BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1982995)

  • 1. [Screening and evaluation on predictive factors in lithium carbonate maintenance treatment of manic-depressive disorders].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Dec; 23(6):324-8, 383. PubMed ID: 1982995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium maintenance: factors affecting outcome.
    Kocsis JH; Stokes PE
    Am J Psychiatry; 1979 Apr; 136(4B):563-6. PubMed ID: 426144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
    Kleindienst N; Severus WE; Greil W
    Int Clin Psychopharmacol; 2007 May; 22(3):125-31. PubMed ID: 17414737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of lithium response in affective disorders.
    Ananth J; Pecknold JC
    J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study.
    Maj M; Starace F; Nolfe G; Kemali D
    Pharmacopsychiatry; 1986 Nov; 19(6):420-3. PubMed ID: 3797469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective evaluation of prophylactic therapy with repeated lithium doses in manic-depressive psychosis based on a pharmacokinetic protocol].
    Domuţa M; Leucuţa SE
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):299-304. PubMed ID: 2951835
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
    Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
    Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of EEG changes with reaction time and serum lithium levels during treatment of manic patients with lithium carbonate].
    Shen JH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Apr; 21(2):83-6, 126-7. PubMed ID: 3145174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
    Swann AC
    Encephale; 2001; 27(3):277-9. PubMed ID: 11488258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the lithium RBC/plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders.
    Knorring L; Oreland L; Perris C; Wiberg A
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):81-4. PubMed ID: 981325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic treatment of manic-depressive psychoses with lithium carbonate. Theoretical and practical value of the study of variations of plasma concentrations].
    Hakim C; Pichot P
    Ann Med Psychol (Paris); 1972 Feb; 1(2):238-46. PubMed ID: 5051251
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Kauer-Sant'Anna M; Bond DJ; Lam RW; Yatham LN
    Compr Psychiatry; 2009; 50(1):1-8. PubMed ID: 19059506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.